This Journal CME activity will examine the prognostic value of coronary flow reserve in patients with suspected or known coronary artery disease referred to PET myocardial perfusion imaging.

This activity is targeted at imaging professionals and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

After reading and reflecting upon this article in the Journal Nuclear Cardiology, the learner should be able to:

• Evaluate the role of CFR in predicting adverse outcome in patients with suspected or known CAD
• Underscore the clinical value of dichotomizing CFR to obtain a prognostic parameter useful in predicting adverse outcome in patients referred to PET MPI
• Provide indication to facilitate better understanding of functional results by PET MPI for appropriate therapeutic strategies

The purpose of this CME activity in the Journal of Nuclear Cardiology is to increase the learners’ competence in the application of nuclear cardiology strategies in clinical practice.

Evaluation Deadlines: AMA PRA Category 1 Credits™, ARRT Category A, and Participation Credits = May 13, 2022
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.



Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credits for Technologists.

Release Date: May 14, 2021
Expiration Date: May 13, 2022